Regeneron Pharmaceuticals research and development expenses for the twelve months ending September 30, 2024 were $4.897B, a 13.76% increase year-over-year.
Regeneron Pharmaceuticals annual research and development expenses for 2023 were $4.439B, a 23.56% increase from 2022.
Regeneron Pharmaceuticals annual research and development expenses for 2022 were $3.593B, a 25.61% increase from 2021.
Regeneron Pharmaceuticals annual research and development expenses for 2021 were $2.86B, a 8.05% increase from 2020.
Regeneron Pharmaceuticals Research and Development Expenses 2010-2024 | REGN